About: Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.47 (-3.52%)
ALT NASDAQ Altimmune Inc
Altimmune Inc share price
ALT price activity
Last Price
$2.470
Change (24hr)
-0.09 USD (-3.52%)
Volume
2.08M
Volume (4w avg)
-
Open
$2.56
Day Range
$2.47 - $2.56
Previous Close
$2.56
Last Trade
13 Oct, 5:32 pm GMT+0
Delayed
13 Oct, 5:32 pm GMT+0
ALT price performance
Delayed
13 Oct, 5:32 pm GMT+0
ALT Market Signals